A study to evaluate a new treatment protocol for post operative orthopaedic constipation

The effect of an evidence based bowel protocol on time taken to return to normal bowel function in post operative major joint replacement patients

Status

Completed

Phases

Unknown

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12612000014853

Enrollment

382

Registered

2012-01-04

Start date

2011-05-01

Completion date

2012-05-18

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The aim of the study is determine whether the administration of polyethylene glycol (Movicol) to post operative total hip and total knee replacement patients results in faster return to normal in the intervention group.

Interventions

Patients at intervention hospitals to receive a post operative bowel protocol based on the adminstration of polyethylene glycol with electrolytes (Movicol) according to bowel type as per the Bristol Stool Chart (BSC). Dosage of Movicol depends on BSC number but maximum dose is one sachet (13.125g Macrogol 3350) per day in two divided doses. This powder is dissolved in 125 ml of water. The intervention lasts for the duration of the inpatient stay usually maximum of 8 days.

Study design

Allocation

Randomised controlled trial

Intervention model

Parallel

Primary purpose

Treatment

Masking

Open (masking not used)

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

Patients undergoing total hip or knee replacement

Exclusion criteria

history or Crohns disease, toxic megacolon, pregnant or breastfeeding, known allergy to polyethylene glycol

Outcome results